Concepts (268)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Craniosynostoses | 9 | 2023 | 62 | 3.620 |
Why?
|
| Reconstructive Surgical Procedures | 8 | 2021 | 202 | 2.270 |
Why?
|
| Orbital Fractures | 3 | 2022 | 6 | 2.040 |
Why?
|
| Osteogenesis, Distraction | 5 | 2022 | 20 | 1.840 |
Why?
|
| Cleft Palate | 9 | 2022 | 24 | 1.670 |
Why?
|
| Bone Transplantation | 6 | 2021 | 53 | 1.540 |
Why?
|
| Pierre Robin Syndrome | 5 | 2022 | 9 | 1.460 |
Why?
|
| Bone Regeneration | 5 | 2023 | 33 | 1.350 |
Why?
|
| Mandible | 6 | 2022 | 39 | 1.290 |
Why?
|
| Craniofacial Dysostosis | 2 | 2022 | 6 | 1.250 |
Why?
|
| Cranial Sutures | 4 | 2022 | 14 | 1.030 |
Why?
|
| Airway Obstruction | 4 | 2022 | 33 | 1.030 |
Why?
|
| Infant | 14 | 2023 | 1123 | 0.990 |
Why?
|
| Periosteum | 4 | 2015 | 9 | 0.970 |
Why?
|
| Tissue Engineering | 7 | 2023 | 700 | 0.970 |
Why?
|
| Skull | 4 | 2020 | 49 | 0.890 |
Why?
|
| Bone Morphogenetic Protein 2 | 3 | 2015 | 22 | 0.890 |
Why?
|
| Cleft Lip | 6 | 2022 | 15 | 0.890 |
Why?
|
| Humans | 46 | 2023 | 34562 | 0.800 |
Why?
|
| Esthetics, Dental | 1 | 2022 | 1 | 0.750 |
Why?
|
| Models, Anatomic | 1 | 2022 | 39 | 0.710 |
Why?
|
| Retrospective Studies | 15 | 2023 | 3825 | 0.710 |
Why?
|
| Germ Cells | 4 | 2011 | 12 | 0.690 |
Why?
|
| Enophthalmos | 1 | 2021 | 2 | 0.670 |
Why?
|
| Zygomatic Fractures | 1 | 2021 | 3 | 0.670 |
Why?
|
| Orbital Implants | 1 | 2021 | 3 | 0.670 |
Why?
|
| Maxillary Fractures | 1 | 2021 | 4 | 0.670 |
Why?
|
| Orbit | 2 | 2020 | 19 | 0.670 |
Why?
|
| Face | 2 | 2018 | 29 | 0.650 |
Why?
|
| Velopharyngeal Insufficiency | 1 | 2020 | 7 | 0.640 |
Why?
|
| Maxilla | 3 | 2020 | 10 | 0.620 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 3 | 2015 | 83 | 0.610 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2020 | 60 | 0.610 |
Why?
|
| Postoperative Hemorrhage | 1 | 2019 | 41 | 0.590 |
Why?
|
| Amniotic Band Syndrome | 1 | 2018 | 1 | 0.580 |
Why?
|
| Hypertelorism | 1 | 2018 | 1 | 0.580 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2018 | 4 | 0.580 |
Why?
|
| Hand Deformities, Congenital | 1 | 2018 | 8 | 0.570 |
Why?
|
| Ganglion Cysts | 1 | 2018 | 8 | 0.570 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 67 | 0.570 |
Why?
|
| Abnormalities, Multiple | 1 | 2018 | 28 | 0.560 |
Why?
|
| Fracture Fixation, Internal | 2 | 2019 | 131 | 0.560 |
Why?
|
| Tracheostomy | 2 | 2018 | 29 | 0.560 |
Why?
|
| Transforming Growth Factor beta | 2 | 2015 | 67 | 0.550 |
Why?
|
| Fibula | 2 | 2021 | 14 | 0.540 |
Why?
|
| Fracture Healing | 1 | 2017 | 44 | 0.510 |
Why?
|
| Pain, Postoperative | 1 | 2019 | 205 | 0.510 |
Why?
|
| Tissue Scaffolds | 4 | 2023 | 435 | 0.500 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2021 | 988 | 0.500 |
Why?
|
| Tibia | 2 | 2021 | 62 | 0.490 |
Why?
|
| Infant, Newborn | 6 | 2022 | 730 | 0.480 |
Why?
|
| Treatment Outcome | 10 | 2023 | 3623 | 0.470 |
Why?
|
| Tibial Fractures | 1 | 2015 | 35 | 0.450 |
Why?
|
| Surgery, Plastic | 3 | 2022 | 29 | 0.430 |
Why?
|
| Female | 23 | 2022 | 21532 | 0.420 |
Why?
|
| Stem Cell Factor | 3 | 2011 | 13 | 0.420 |
Why?
|
| Cell Movement | 4 | 2011 | 182 | 0.400 |
Why?
|
| Craniotomy | 3 | 2023 | 46 | 0.370 |
Why?
|
| Ultrasonics | 4 | 2006 | 22 | 0.360 |
Why?
|
| Sutures | 2 | 2022 | 20 | 0.360 |
Why?
|
| Occipital Bone | 2 | 2022 | 18 | 0.360 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2008 | 16 | 0.340 |
Why?
|
| Male | 21 | 2021 | 20740 | 0.330 |
Why?
|
| Animals | 11 | 2017 | 8579 | 0.310 |
Why?
|
| Child | 9 | 2023 | 2614 | 0.310 |
Why?
|
| Recombinant Proteins | 4 | 2015 | 281 | 0.310 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2006 | 40 | 0.300 |
Why?
|
| Orthopedic Procedures | 2 | 2020 | 101 | 0.290 |
Why?
|
| Swine | 3 | 2015 | 233 | 0.290 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2010 | 183 | 0.280 |
Why?
|
| Osteogenesis | 3 | 2023 | 81 | 0.280 |
Why?
|
| Stem Cell Transplantation | 1 | 2010 | 229 | 0.280 |
Why?
|
| Apoptosis | 2 | 2008 | 400 | 0.270 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2008 | 12 | 0.270 |
Why?
|
| Embryo, Mammalian | 2 | 2009 | 35 | 0.270 |
Why?
|
| Nasal Septum | 2 | 2018 | 4 | 0.260 |
Why?
|
| Ilium | 2 | 2016 | 16 | 0.250 |
Why?
|
| Cell Membrane Permeability | 1 | 2006 | 19 | 0.250 |
Why?
|
| Fellowships and Scholarships | 2 | 2017 | 56 | 0.240 |
Why?
|
| Postoperative Complications | 3 | 2020 | 850 | 0.230 |
Why?
|
| Surgical Flaps | 2 | 2020 | 78 | 0.230 |
Why?
|
| Facial Bones | 2 | 2018 | 9 | 0.230 |
Why?
|
| Cell Proliferation | 1 | 2006 | 633 | 0.210 |
Why?
|
| Surgical Equipment | 2 | 2020 | 10 | 0.210 |
Why?
|
| Ink | 1 | 2023 | 11 | 0.200 |
Why?
|
| Transplantation, Homologous | 2 | 2015 | 165 | 0.190 |
Why?
|
| Corneal Dystrophies, Hereditary | 1 | 2022 | 1 | 0.190 |
Why?
|
| Iris Diseases | 1 | 2022 | 1 | 0.190 |
Why?
|
| Hypopigmentation | 1 | 2022 | 7 | 0.190 |
Why?
|
| Nerve Transfer | 1 | 2022 | 19 | 0.190 |
Why?
|
| Foramen Magnum | 1 | 2022 | 1 | 0.180 |
Why?
|
| Computers | 1 | 2022 | 22 | 0.180 |
Why?
|
| Neurosurgical Procedures | 1 | 2022 | 101 | 0.180 |
Why?
|
| Cone-Beam Computed Tomography | 2 | 2018 | 21 | 0.170 |
Why?
|
| Neuroendoscopy | 1 | 2020 | 4 | 0.170 |
Why?
|
| Internship and Residency | 2 | 2022 | 330 | 0.160 |
Why?
|
| Pharynx | 1 | 2020 | 14 | 0.160 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2020 | 8 | 0.160 |
Why?
|
| Osteotomy | 2 | 2023 | 57 | 0.160 |
Why?
|
| Prostheses and Implants | 1 | 2020 | 53 | 0.160 |
Why?
|
| Bone Neoplasms | 1 | 2021 | 122 | 0.160 |
Why?
|
| Jaw Fixation Techniques | 1 | 2019 | 2 | 0.150 |
Why?
|
| Mandibular Fractures | 1 | 2019 | 7 | 0.150 |
Why?
|
| Adipose Tissue | 2 | 2014 | 366 | 0.150 |
Why?
|
| Craniofacial Abnormalities | 3 | 2017 | 14 | 0.140 |
Why?
|
| Dizziness | 1 | 2018 | 9 | 0.140 |
Why?
|
| Cell Differentiation | 2 | 2014 | 485 | 0.140 |
Why?
|
| Mandibulofacial Dysostosis | 1 | 2018 | 1 | 0.140 |
Why?
|
| Anesthesia, General | 1 | 2018 | 35 | 0.140 |
Why?
|
| Headache | 1 | 2018 | 78 | 0.140 |
Why?
|
| Palatal Obturators | 1 | 2018 | 1 | 0.140 |
Why?
|
| Neuralgia | 1 | 2018 | 47 | 0.140 |
Why?
|
| Dipyridamole | 1 | 2017 | 3 | 0.140 |
Why?
|
| Ceramics | 1 | 2017 | 7 | 0.140 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2017 | 5 | 0.130 |
Why?
|
| Intubation, Intratracheal | 1 | 2018 | 74 | 0.130 |
Why?
|
| Intracranial Pressure | 1 | 2017 | 17 | 0.130 |
Why?
|
| Green Fluorescent Proteins | 2 | 2008 | 72 | 0.130 |
Why?
|
| Maxillary Neoplasms | 1 | 2016 | 2 | 0.130 |
Why?
|
| Professional Practice Location | 1 | 2016 | 1 | 0.130 |
Why?
|
| Goldenhar Syndrome | 1 | 2016 | 3 | 0.130 |
Why?
|
| Alveolar Ridge Augmentation | 1 | 2016 | 2 | 0.130 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 265 | 0.130 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 542 | 0.130 |
Why?
|
| Nasal Obstruction | 1 | 2016 | 5 | 0.120 |
Why?
|
| Time Factors | 2 | 2020 | 2353 | 0.120 |
Why?
|
| Surgical Instruments | 1 | 2016 | 25 | 0.120 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2016 | 27 | 0.120 |
Why?
|
| Cartilage | 1 | 2016 | 33 | 0.120 |
Why?
|
| Outpatients | 1 | 2016 | 61 | 0.120 |
Why?
|
| Combined Modality Therapy | 2 | 2016 | 590 | 0.120 |
Why?
|
| Developmental Disabilities | 1 | 2016 | 18 | 0.120 |
Why?
|
| Career Choice | 1 | 2016 | 45 | 0.120 |
Why?
|
| Publishing | 1 | 2017 | 66 | 0.120 |
Why?
|
| Ribs | 1 | 2016 | 47 | 0.120 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 168 | 0.120 |
Why?
|
| Case-Control Studies | 4 | 2018 | 926 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2017 | 186 | 0.110 |
Why?
|
| Mice | 4 | 2011 | 2720 | 0.110 |
Why?
|
| Parents | 1 | 2016 | 159 | 0.110 |
Why?
|
| Biofilms | 2 | 2004 | 23 | 0.110 |
Why?
|
| Wound Healing | 1 | 2015 | 190 | 0.110 |
Why?
|
| Pliability | 1 | 2014 | 4 | 0.100 |
Why?
|
| Tissue Preservation | 1 | 2014 | 8 | 0.100 |
Why?
|
| Costs and Cost Analysis | 1 | 2014 | 113 | 0.100 |
Why?
|
| Chondrogenesis | 1 | 2014 | 20 | 0.100 |
Why?
|
| X-Ray Microtomography | 1 | 2014 | 45 | 0.100 |
Why?
|
| Absorbable Implants | 1 | 2014 | 27 | 0.100 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2014 | 37 | 0.100 |
Why?
|
| Stress, Mechanical | 1 | 2014 | 102 | 0.100 |
Why?
|
| Cohort Studies | 2 | 2016 | 1910 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2011 | 73 | 0.100 |
Why?
|
| Clinical Competence | 1 | 2016 | 349 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2019 | 1508 | 0.100 |
Why?
|
| Facial Transplantation | 1 | 2013 | 8 | 0.100 |
Why?
|
| Models, Animal | 1 | 2014 | 198 | 0.100 |
Why?
|
| Adult | 5 | 2019 | 10030 | 0.100 |
Why?
|
| Allantois | 2 | 2011 | 3 | 0.100 |
Why?
|
| Length of Stay | 1 | 2014 | 335 | 0.100 |
Why?
|
| Scalp | 1 | 2013 | 38 | 0.100 |
Why?
|
| Cell Culture Techniques | 1 | 2014 | 177 | 0.100 |
Why?
|
| Bone and Bones | 2 | 2023 | 99 | 0.100 |
Why?
|
| Collagen | 1 | 2014 | 240 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 1393 | 0.090 |
Why?
|
| Ultrasonic Therapy | 2 | 2009 | 4 | 0.090 |
Why?
|
| Cell Membrane | 1 | 2011 | 111 | 0.090 |
Why?
|
| Child, Preschool | 3 | 2021 | 1355 | 0.080 |
Why?
|
| Osteotomy, Le Fort | 1 | 2009 | 3 | 0.080 |
Why?
|
| Middle Aged | 3 | 2019 | 12726 | 0.080 |
Why?
|
| Quadriceps Muscle | 1 | 2010 | 35 | 0.080 |
Why?
|
| Mice, Knockout | 2 | 2009 | 486 | 0.080 |
Why?
|
| Stem Cell Niche | 1 | 2009 | 27 | 0.070 |
Why?
|
| Sacrococcygeal Region | 1 | 2008 | 6 | 0.070 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2008 | 20 | 0.070 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2008 | 10 | 0.070 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 56 | 0.070 |
Why?
|
| DNA Primers | 1 | 2008 | 92 | 0.070 |
Why?
|
| Cell Survival | 2 | 2009 | 304 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2008 | 80 | 0.070 |
Why?
|
| Gestational Age | 1 | 2008 | 134 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2008 | 124 | 0.070 |
Why?
|
| Base Sequence | 1 | 2008 | 265 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2008 | 154 | 0.060 |
Why?
|
| Mice, Transgenic | 1 | 2008 | 279 | 0.060 |
Why?
|
| Gonads | 1 | 2006 | 3 | 0.060 |
Why?
|
| Mesentery | 1 | 2006 | 6 | 0.060 |
Why?
|
| Genitalia | 1 | 2006 | 9 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 1607 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2006 | 24 | 0.060 |
Why?
|
| Edetic Acid | 1 | 2006 | 9 | 0.060 |
Why?
|
| Cephalosporins | 1 | 2006 | 9 | 0.060 |
Why?
|
| Hydrolysis | 1 | 2006 | 42 | 0.060 |
Why?
|
| Cadaver | 3 | 2013 | 170 | 0.060 |
Why?
|
| Young Adult | 3 | 2019 | 2831 | 0.060 |
Why?
|
| Odds Ratio | 2 | 2018 | 480 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 2 | 2004 | 352 | 0.050 |
Why?
|
| Gentamicins | 1 | 2004 | 5 | 0.050 |
Why?
|
| Staphylococcus epidermidis | 1 | 2004 | 6 | 0.050 |
Why?
|
| Vancomycin | 1 | 2004 | 24 | 0.050 |
Why?
|
| Escherichia coli | 1 | 2004 | 92 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 2367 | 0.050 |
Why?
|
| Micelles | 1 | 2002 | 7 | 0.050 |
Why?
|
| Iris | 1 | 2022 | 7 | 0.050 |
Why?
|
| Epoxy Compounds | 1 | 2002 | 10 | 0.050 |
Why?
|
| Personal Satisfaction | 1 | 2022 | 28 | 0.050 |
Why?
|
| Head | 1 | 2022 | 61 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2002 | 112 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2013 | 323 | 0.040 |
Why?
|
| Executive Function | 1 | 2020 | 60 | 0.040 |
Why?
|
| Reference Values | 1 | 2020 | 265 | 0.040 |
Why?
|
| Nose | 1 | 2020 | 12 | 0.040 |
Why?
|
| Adolescent | 2 | 2018 | 3805 | 0.040 |
Why?
|
| Bone Screws | 1 | 2019 | 64 | 0.040 |
Why?
|
| Fiber Optic Technology | 1 | 2018 | 15 | 0.040 |
Why?
|
| Bone Plates | 1 | 2019 | 74 | 0.040 |
Why?
|
| Laryngeal Masks | 1 | 2018 | 14 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 197 | 0.040 |
Why?
|
| Device Removal | 1 | 2018 | 44 | 0.030 |
Why?
|
| Bone Remodeling | 1 | 2017 | 10 | 0.030 |
Why?
|
| Polysomnography | 1 | 2017 | 41 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 703 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2017 | 104 | 0.030 |
Why?
|
| Reoperation | 1 | 2018 | 265 | 0.030 |
Why?
|
| Sheep | 1 | 2017 | 233 | 0.030 |
Why?
|
| Publications | 1 | 2017 | 9 | 0.030 |
Why?
|
| North America | 1 | 2016 | 34 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2017 | 48 | 0.030 |
Why?
|
| Canada | 1 | 2016 | 69 | 0.030 |
Why?
|
| Hospital Costs | 1 | 2016 | 51 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2017 | 81 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 305 | 0.030 |
Why?
|
| North Carolina | 1 | 2020 | 1613 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 808 | 0.030 |
Why?
|
| Software | 1 | 2016 | 130 | 0.030 |
Why?
|
| Child Development | 1 | 2016 | 47 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2016 | 138 | 0.030 |
Why?
|
| Carotid Artery, External | 1 | 2013 | 2 | 0.020 |
Why?
|
| Cranial Nerves | 1 | 2013 | 7 | 0.020 |
Why?
|
| Jugular Veins | 1 | 2013 | 27 | 0.020 |
Why?
|
| Solubility | 1 | 2011 | 43 | 0.020 |
Why?
|
| Cell Count | 1 | 2011 | 55 | 0.020 |
Why?
|
| Protein Binding | 1 | 2011 | 255 | 0.020 |
Why?
|
| Dissection | 1 | 2010 | 18 | 0.020 |
Why?
|
| Soft Tissue Injuries | 1 | 2010 | 20 | 0.020 |
Why?
|
| Zygoma | 1 | 2009 | 3 | 0.020 |
Why?
|
| Eyelids | 1 | 2009 | 8 | 0.020 |
Why?
|
| Cheek | 1 | 2009 | 6 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2011 | 545 | 0.020 |
Why?
|
| Endoscopy | 1 | 2009 | 56 | 0.020 |
Why?
|
| Digestive System | 1 | 2009 | 5 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2009 | 40 | 0.020 |
Why?
|
| Mutation | 1 | 2011 | 532 | 0.020 |
Why?
|
| Cell Death | 1 | 2009 | 85 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 614 | 0.020 |
Why?
|
| United States | 1 | 2017 | 4278 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2009 | 771 | 0.010 |
Why?
|
| Biological Transport | 1 | 2004 | 76 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2004 | 83 | 0.010 |
Why?
|
| Prosthesis-Related Infections | 1 | 2004 | 32 | 0.010 |
Why?
|
| Rabbits | 1 | 2004 | 231 | 0.010 |
Why?
|
| Staphylococcal Infections | 1 | 2004 | 83 | 0.010 |
Why?
|
| Membranes, Artificial | 1 | 2002 | 8 | 0.010 |
Why?
|
| HL-60 Cells | 1 | 2002 | 14 | 0.010 |
Why?
|
| Hela Cells | 1 | 2002 | 82 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 55 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 180 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 755 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2002 | 198 | 0.010 |
Why?
|